Gowri Chellappan is a Senior Scientist & Project Manager at Inventprise, where they manage vaccine formulation process development. Prior to this, they worked as a Scientist at GlaxoSmithKline Pharma GmbH, where they led the team in selection of RNA DS buffer utilizing orthogonal RNA conc. analysis methods, stability indicating assays for RNA integrity, frozen storage and temperature excursions studies and RNA potency. Gowri has also conducted extensive pre-formulation studies involving pH, buffer, excipients and adjuvants screening for selection of stable and potent nucleic/protein formulations for in vivo delivery. Gowri Chellappan's expertise in microfluidic platforms for large scale vaccine formulation with optimal attributes has made their an invaluable asset to Inventprise.
Gowri Chellappan earned their Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Massachusetts Lowell. Gowri also holds a Bachelor of Technology (B.Tech.) in Biotechnology from Anna University.